Chapter 18/19 Flashcards
Alpha 1 Adrenergic Function
- Increase cardiac contractility and vasoconstriction
- Dilate Pupils, decrease salivary gland secretion
- Increase bladder and prostate contraction
Alpha 2 Adrenergic Function
- Inhibit norepinephrine release
- Decrease GI motility and tone
Beta 1 Adrenergic Function
- Increase Cardiac contractility
- Increase renin secretion
Beta 2 Adrenergic function
- Decreases GI tone and motility
- Activates liver glycogenolysis
- Bronchodilation
- Increases blood flow in skeletal muscles
- decreases uterine tone
Inactivation of Neurotransmitters
- reuptake of the transmitter back into the neuron
- enzymatic transformation or degradation
- diffusion away from the receptor
2 Enzymes that inactivate the metabolism of norepinephrine
- Monoamine oxidase (MAO)
2. Catechol-O-methyltransferase (COMT)
How do drugs stop the termination of the neurotransmitter?
- By inhibiting the norepinephrine reuptake, which prolongs the action of the transmitters
- inhibiting the degradation of norepinephrine by enzyme action
Adrenergic agonists
sympathomimetics or adrenomimetics
adrenergic blockers
sympatholytics or adrenolytics
Where are adrenergic receptor sites?
cells of muscles such as heart, bronchiole walls, GI tract, urinary bladder, and ciliary muscle
Categories of sympathomimetics
- direct-acting (directly stimulate: epinephrine/norepinephrine)
- indirect-acting (stimulate the release of norepinephrine from terminal nerve endings: amphetamine)
- mixed-acting (both direct and direct which stimulate the adrenergic receptor sites and stimulate release of norepinephrine from terminal nerve endings: ephedrine)
Epinephrine
- Nonselective
- Action: Alpha 1, Beta 1 and 2
- Contraindications: dysrhythmias, cerebral arteriosclerosis, pregnancy, narrow angle-glaucoma, cardiogenic shock.
- PK: subq/im/iv
- Quick onset–> lasts 1 to 3 hrs
- Action: inotropic, vasoconstrictor, bronchodilator
Albuterol
Selective: B2 adrenergic
- treat bronchospasm, asthma, bronchitis, COPD
- Side effects: tremors, dizziness, hallucinations, cardia dysrhythmias
- Increase effect with other sympathomimetics,MAO inhib, TCAs
Adrenergic blockers OR sympatholytics
- Block by occupying receptors (Directly)
- By inhibiting the release of norep/epi (indirectly)
Alpha-Adrenergic blockers
- Selective: block A1
- Nonselective: block A1/A2